to PDF

Issue 4 | July 2016
Corin’s Optimized
Positioning System (OPS™)
receives 510(k) clearance
Corin is pleased to announce United States 510(k)
clearance of the Optimized Positioning System (OPS™),
the first FDA-cleared technology to help surgeons achieve
functional, patient specific component alignment in total
hip replacement.
The approval allows Corin to be the first company to offer a
technology that optimises the orientation of each individual
patient’s acetabular component by incorporating functional
assessments into the planning phase, whilst utilising
a laser-guided Patient Specific Instrument platform to
accurately reproduce the surgical plan intraoperatively.
Following the acquisition of the technology in 2014 a
significant number of procedures in Australia and Europe
have been completed, Corin now look forward to launching
OPS™ in the world’s largest orthopaedic market. The
combination of the IP-protected OPS™ technology,
alongside the company’s strong hip portfolio and
rapidly expanding distribution network, provide a strong
foundation for future growth of the company.
Jim Pierrepont, Corin’s Head of Procedural Technologies
commented “We are delighted to gain access to the
US market and be the first company to offer such an
exciting technology. This solution is a significant step
forward in helping to improve the performance of total hip
replacement, as conventional acetabular cup placement
does not take into account the patient’s individual
functional movement and relies instead on guidance for
cup positioning defined some 36 years ago”.
Pierrepont went on to say “By commercialising the OPS™
technology, Corin will offer surgeons and patients a unique
customised, patient specific solution for hip surgery that
will help to provide optimal implant positioning with the goal
of improved functional outcome”.
Corin’s US President, Paul Berman added “OPS™ is the
first orthopaedic technology to facilitate functional implant
positioning without adding complexity or substantial cost to
the surgical procedure. We are excited to be bringing this
technology to the US to further advance orthopaedic care.”
4
Interview with renowned
orthopaedic surgeon
Miss Sarah Muirhead-Allwood, London Hip Unit, London, UK
6
Why I came to adopt the MiniHip™
David Watson MD, Florida
Orthopaedic Institute, Tampa, USA
7
My experiences with
Zenith™ TAR
Mr Shashi Garg, Westmorland
General Hospital, Kendal, UK
9
Use of Revival™ in
treatment of CDH/DDH
Mr Duncan Whitwell, Nuffield
Orthopaedic Centre, Oxford, UK
Corporate news
COMPANY NEWS
Australia
Patients are becoming
more informed and active
decision makers in their
surgical experience, with many using
online and digital resources to better
understand their condition and treatment
options. The Australian designed OPS™
LCD brochures are equipping surgeons
with patient education tools aligned
with their consultation dialogue. Corin
is committed to investing in education
resources that empower patients
by directing them to trustworthy
information supporting their surgeon’s
treatment preferences which can have a
significant impact on treatment outcomes
and patient satisfaction. The OPS™ LCD
brochures are pre-loaded with an autoplay video outlining the OPS™ total hip
replacement process and rationale. They
complement Corin’s existing suite of
print and online education brochures and
enable patients to engage their family,
friends and allied health support network
in their treatment pathway.
To view the
OPS™ patient
LCD brochure
and see
how these
educational
tools can
support your
practice please visit: www.bit.ly/1TfEi9z
Japan
Corin is delighted to
announce the introduction
of TriFit TS™ into Japan.
TriFit TS™ was approved for use in
March 2016 and is an excellent addition
to MiniHip™, CTi II™ and Trinity™ cup
which already have approval.
This opens up another option for
surgeons in Japan wanting to use a
modern blade style stem. Dr Funayama
of Keio University commented that he
saw a real need for this type of short
blade stem with calcium phosphate
coating, designed anatomically with high
offset option in Japan. In its first month
of launch 20 stems have been implanted
by seven surgeons. Dr Kim of Hanwa
Reconstruction Centre commented that
he feels implanting TriFit TS™ stems is
stress free surgery compared with other
blade stems and the instruments are
simple and easy to use.
Corin look forward
to a continued close
working relationship
with Japanese surgeons as
we continue to develop the
business in Japan.
2
Company update
Vaughan Bonny, General Manager, Australia and New Zealand
reflects on his first six months at Corin
My time has been action packed and a lot of fun since joining
the Corin team. I feel fortunate to have joined Corin at such
an exciting time in its evolution. The momentum building in
Australia and New Zealand as well as globally is exciting to be
a part of. There is no doubt in my mind that Corin is extremely
well placed in the market.
As I reflect on the last six months, there has been an
exceptional amount of activity. We have run and sponsored
several major meetings,
Vaughan Bonny
expanded our sales
network in three states, record numbers of
surgeons are booking first hip cases, record OPS™
volumes have been achieved, increased LARS™
usage in the gluteal repair indication by 35% and
finally we signed a deal to become the exclusive
distributor for intellijoint HIP™ (smart hip navigation
technology) at the AAOS in March. I’m sure most
would agree the Corin Australia, New Zealand and
the Optimized Ortho teams have been running fast
in Q1 and are doing a sensational job! Pleasingly all
of this activity is yielding results: 15 new LARS™
customers and 12 new OPS™ customers are
trialling. Exciting times!
Armen Bakirtzian, Co-founder and
At our national sales meeting I shared with our
CEO Intellijoint Surgical (left)
organisation the reasons why I was attracted to
Russ Mably COO Corin (right)
Corin. Quite clearly for me it’s the potential of the
whole organisation, both people and products. Corin has embraced the advancement
of procedural technologies well ahead of the market. Of course being an Aussie it’s
hard not to mention our locally developed OPS™ technology. This is an amazing piece
of technology that seeks to provide a patient specific orientation for implants in total
hip replacement surgery. Having seen many podium presentations on the benefits
of this product there is no doubt the Optimized Ortho team have only scratched the
surface in this space. Taking this a step further, OPS™ in combination with Corin’s
market leading implants is an envious position to be in. So being six months into the
role I am feeling bullish on the commercial outlook for Corin ANZ.
Our people, put simply we have a fantastic team. I believe as we continue to develop
our talent base, expand our sales network and grow as a business we will build a
great company that people want to be part of.
Finally and arguably most importantly, it’s Corin’s ability to be nimble in the market
and react to what our surgeon customers require to provide the best possible
surgical experience for them and their patients. To me that embodies our tag line
of ‘Responsible Innovation’ and makes it a delight to engage with our surgeon
customers. In my mind we should never lose sight of our customers and their needs.
Certainly, my first six months at Corin would suggest we are on the right track here.
I believe 2016 holds a lot of promise and I’m delighted to be part of the team.
Corin Australia and Optimized Ortho teams.
Technology news
The femoral story. . . the next chapter in The evolution of OPS™ continues with
the recent addition of the femoral planning
tool. Prosthesis type and size can now
be virtually positioned to understand
changes in leg length, offset and femoral
version and their impact on the patient’s
hip alignment. Once the plan has been
agreed, a 3D printed patient specific
osteotomy guide is provided, enabling
simple and accurate intraoperative
implementation (Riddell et al. 2015).
Since 2013, Corin’s Optimized Positioning
System (OPS™) has been used in over
2500 total hip replacement surgeries in
Australia, Germany, Austria and the UK,
enabling preoperative functional analysis
for each patient. The femoral planning
system complements Corin’s unique
OPS™ acetabular planning platform
to provide a comprehensive total hip
replacement solution.
replacement. This 3D–based femoral plan
also contains detailed information to flag key
‘watch-outs’ to the surgeon preoperatively,
thereby reducing unexpected decision
complexities within the operating room.
The product is soon to be released more
widely as interest continues to grow in key
markets around the globe. Importantly, the
technology continues to be supported by
a strong foundation of clinical research,
with multiple case series being exhibited at
a number of key orthopaedic congresses.
This year results have been presented
at meetings including ICJR (Sydney),
JSRA (Osaka), AAOS (Orlando), COMOC
(Capetown) and will continue at SICOT
(Rome), BOA (Belfast), ISTA (Boston),
AOA (Cairns) and DKOU (Berlin).
Dr Christoph
Schnurr
Verbund
Katholischer
Kliniken
Düsseldorf,
Germany
What do you see as the major
challenges in THR today?
A key challenge in total hip replacement is
the ability of the surgeon to correctly select
and orient prostheses intraoperatively.
To do this appropriately, a thorough
understanding of a number of patient
specific variables is required. One of the
most significant factors is the dynamic
behavior of the pelvis and lumbar spine
– which can vary significantly from one
patient to the next. This variation can
provide important information to the
surgeon to help make the most appropriate
™
technology
decision as to the design of prosthesis and
bearing surface to be utilised in surgery.
What role do patient specific factors play
when planning and performing a THR?
Patient specific variables play a key role
in the planning and execution of a total
hip replacement. Aspects such as age,
gender, weight, sports activities, physical
and psychological health status need to
be carefully considered in the planning
phase. Knowledge of these factors helps
the surgeon to better profile each patient
and understand their postoperative
expectations. Further, by understanding
the dynamics of the pelvis and lumbar
spine in functional positions, we can
better comprehend their range of motion
requirements as well as the risk of instability
during flexion and extension manoeuvers.
How do you use the information provided
by OPS™ in your THR practice?
OPS™ provides detailed, patient specific
information for me to better plan and
execute a total hip replacement. The
preoperative dynamic analysis provides
key information that enables me to target
and achieve a personalised safe zone
for the placement of the acetabular
component. In addition, OPS™ also gives
me the ability to accurately reconstruct
leg length and offset, giving me added
confidence that function and stability
are better restored postoperatively. In
combination, this has given me the ability to
optimise outcomes and achieve predictably
high levels of patient satisfaction.
To find out more about this exciting
technological advancement and how
OPS™ technology may benefit your
practice please visit www.bit.ly/1XfkZyv
“Femoral OPS™ gives me another level
of confidence that the femoral implant
ends up where I want it to be, particularly
in regards to the leg length”
Dr Jorgen Hellman – over 100 OPS™ THR’s
Early validation work has shown
encouraging results, with 85% of achieved
osteotomies being executed to within 1mm
of the preoperative plan (Riddell et al. 2015).
By accurately controlling the resection
level, the surgeon has the potential to
better control biomechanical parameters,
while also managing the definitive position
of the femoral component during total hip
Responsible Innovation
3
Global surgeon feature
Interview with world-renowned orthopaedic surgeon
– Miss Sarah Muirhead-Allwood
Miss Sarah
Muirhead-Allwood
MB BS FRCS
London Hip Unit,
London, UK
Miss Sarah Muirhead-Allwood qualified
in medicine from St Thomas' Hospital
in London. She was appointed as a
Consultant Orthopaedic Surgeon at
the Whittington Hospital in London and
the Royal Northern Hospital in 1984.
The same year she was also appointed
as Honorary Senior Clinical Lecturer at
University College London. In 1991 she
was appointed as a Consultant at the
Royal National Orthopaedic Hospital, where
she remains an Honorary Consultant. For
the last 15 years Miss Muirhead-Allwood
has exclusively performed primary and
revision hip surgery, and lectures on these
procedures all over the world. She is a
member of the British, European and
International Hip Societies. Miss MuirheadAllwood set up the London Hip Unit in 2002
to provide a fully supported specialised
service for adults with hip problems. In her
spare time Miss Muirhead-Allwood enjoys
golf and photography.
1. What do you see as the most
important changes in hip arthroplasty in
the last ten years?
I think the biggest change is the
improvements in coatings, but more
particularly bearing surface technology.
Over the last decade within Europe
we have seen an increase in ceramicon-ceramic hips which are performing
well and data shows a more normal
tissue reaction around ceramic debris.
However the improvements in plastic
technology have been even greater, and
the understanding of poly treatment has
revolutionised our practice.
HXLPE seems to give better 20 years
survivorship over UHMWPE.
The addition of vitamin E poly may well
produce a bearing surface with the ability
to compete against ceramic-on-ceramic for
30 years survivorship.
4. What changes do you think are likely to
occur in THA in the next five years?
I may retire which will leave the total hip
replacement world in disaster. Joking aside I
feel that technology will play a bigger role in
orthopaedics in the future.
The other area I feel technology will affect
future surgery will be the use of ALM (additive
layer manufacture) in component production.
This will almost certainly reduce costs but also
address issues with implant stiffness.
2. What do you see as the issues/
unsolved problems in THA today?
5. What changes have you seen in your
patient population and expectations for
total joint replacement during your career?
Many of the previous issues in THR have
been addressed. We have now mastered
implant fixation at the bony interface using
porous metals and even cement, plus
we now have access to bearing surfaces
which seem to show longevity of 30 years.
Early in my career my major interest was in
revision hip surgery as I trained and became
a Consultant at a time where total hip
replacements were failing in large numbers.
These failures needed to be revised to a more
time lasting solution.
However, bone loss around the implant due
to prosthesis rigidity still seems to be an
issue. Previous attempts have been made
to make a more flexible hip replacement
prosthesis. As we are now able to
manufacture using modern technology we
should in theory be able to make products
which mimic the natural anatomy.
This ultimately led to a search for a primary
THR with better longevity. Today my revision
practice is much smaller, which in part reflects
the low failure rates of the THRs I have
performed over the last 20 years.
3. What place do you think technology
has in THA today and in the future?
Though we have introduced various
technologies the results of hip replacement
would suggest we still have a high failure
rate particularly when looking at dislocation
and wear of the implant.
A better understanding of what the
functional anteversion of the socket
should be, combined with the knowledge
of PSI, could improve our understanding
of cup placement.
No doubt the threshold of primary THR has
lowered. When I became a Consultant a
patient who was able to walk as far as a
mile would not be considered appropriate
for THR surgery. Today patients have high
aspirations following THR surgery, and many
expect to be able to ski, run and play sports
such as tennis.
6. Has this led to any differences in your
approach to treating patients today?
I have always sought to use prostheses which
provide the optimal function and longevity
for each patient. I still believe resurfacing
is a good option for young, fit men and
statistically functions better than THR in this
group of patients. This is to do with the ability
to maintain stiffness in
the upper femoral neck.
Trinity™
Advanced Bearing Acetabular System
All opinions and advice expressed in this article are the surgeon’s and may not represent the opinions of Corin Group or its affiliates. Use of any orthopaedic implant should be in line with the IFU
guidelines and associated surgical technique.
4
Company News
Intellijoint Surgical and Corin Group enter strategic
partnership for intellijoint HIPTM
Corin and Intellijoint Surgical Inc
have recently entered into a strategic
partnership for distribution rights for
Intellijoint’s flagship product, intellijoint
HIP™, in Australia and paves the way for
broader distribution and co-development
between the two companies.
intellioint HIP™ provides orthopaedic
surgeons with vital intraoperative
measurements in real time, enabling
accurate delivery of the target cup
orientation, equalisation of leg length and restoration of hip offset. These critical
measurements enable surgeons and
hospitals to improve surgical outcomes
by reducing uncertainty and risk, while
improving patient outcomes and economics.
Russ Mably, Corin’s Chief Operating Officer
commented “We
are delighted to
partner with such a
progressive company
as Intellijoint Surgical,
and are excited
about our future
collaboration. This
partnership will further
strengthen our market
leading position in
functional implant
positioning with
our existing OPS™
(Optimized Positioning
System) technology, and underlines our
commitment to continue to invest in
personalised procedural innovation”.
Armen Bakirtzian, Chief Executive
Officer and Co-founder of Intellijoint
Surgical further commented “We
are pleased to partner with Corin to
offer intellijoint HIP™ to surgeons
in Australia. The broader capability
of Corin’s organisation and their
commitment to innovation will expand
access to the latest technology
available for 3D surgical measurement
for the growing Australian hip
replacement market where surgeons
currently perform about 45,000
procedures annually. We look forward
to the beginning of a meaningful
relationship between our two
companies and are excited about
future opportunities”.
To learn more about intellijoint HIP™
please visit http://bit.ly/28J3we3
Unity Knee™ – The clinical evidence is building...
The Unity Knee™ system was designed to address
the long standing issues in total knee replacement and
strive to target and improve patient satisfaction and
quality of life post-surgery. Since the launch of the
system in 2012, Corin has been dedicated
to clinical research with a robust clinical
programme investigating topics such
as MCL isometry as well as short-term
functional outcomes. Two papers
have recently been published and
are available online in US journal
Reconstructive Review reporting
excellent survivorship and functional
outcomes in the cruciate retaining
and posterior stabilising designs.
Kreuzer et al. (2016) reported the
early outcome of Unity Knee™ CR
KOOS results and also compared
them to Triathlon® CR results
reported in a recent paper by Molt et
al. (2014). The Unity Knee™ scores
are comparatively higher than that of
Triathlon® demonstrating excellent
functional outcomes when compared
with this other popular system.
Corin continues to take a proactive approach in
collecting clinical data with a number of global
studies currently running. We expect to have
further publications available on the system over
the coming months to further build on these early
results and support of the Unity Knee™.
Product update
Unity Knee™ first stems implanted
The Unity Knee™ offers the unique ability
to stem a primary PS femur and tibia for
use in difficult primary situations where
additional stability is required. The first
Unity Knee™ stems have been implanted
by Dr Stefan Kreuzer (USA), Dr Tom
McCoy (USA) and Professor Johan
Bellemans (Belgium) in the first
phase of the design surgeon
evaluation. Instrument
and implant feedback
from these initial
cases has been very
positive as well as the
patients performance
and satisfaction
postoperatively. The
DPI instrument sets
are currently being
manufactured for global
evaluation with non-design
surgeons which will begin
later in the year before broad
launch of the system.
For more information on the Unity Knee™ system
and to access the clinical news papers please
visit the following link www.bit.ly/1TPKLbw
Responsible Innovation
5
Global surgeon feature
COMPANY NEWS
Why I came to adopt the MiniHip™
USA
2016 began with a
strong presence at
AAOS in Orlando, FL
where over 90 individuals attended
Corin’s ‘Form to Function’ educational
dinner from Argentina, Australia, Brazil,
Ecuador, Germany, The Netherlands, UK
and the USA. The event was hosted by
Corin’s KOLs, Stefan Kreuzer, MD, John
Masonis, MD, Charlie DeCook, MD and
Jim Pierrepont presenting on a range of
topics from biomechanical restoration
in DA approach THA with MiniHip™,
restoration of functional soft tissue
isometry and anatomic component
positioning in TKA with the Unity
Knee™ and the world-first Optimizing
Positioning System (OPS™) technology.
The evening generated a lot of lively
debate and provided attendees with the
opportunity to share their opinions with
their colleagues from around the world.
The first MetaFix™ collared hip stems
were successfully implanted in Q1 by
Dr Juan Suarez of The Cleveland Clinic
in Weston, FL and Dr Steve Barnett of
HOAG Orthopaedic Institute in Irvine,
CA following the FDA 510(k) clearance
in the USA. This innovative stem system
is based on a long-term proven design
philosophy and with the recent clearance
in the USA this provides surgeons with
a full range of ‘collared HA-coated
stems’ and unique option of ‘short neck’
variants to provide a truly customised
approach to individual patient
anatomical variations.
Q1s success has been followed in Q2
with the announcement of the 510(k)
clearance for the Revival™ Modular
Revision Hip Stem and more recently
the OPS™ technology. These additions
to Corin’s hip and knee portfolio will
further accelerate growth in the US
market and more importantly provide
surgeons with greater options for
patients requiring hip surgery.
Revival™
David Watson, MD,
Florida Orthopaedic
Institute, Tampa,
Florida, USA
David T. Watson, MD, specialises
in Orthopaedic Trauma and Adult
Reconstruction and Arthritis Surgery. He
received his Medical degree from Dalhousie
University in Halifax, Nova Scotia, Canada
and performed his Orthopaedic Residency
and Internship training at Queen's
University in Kingston, Ontario, Canada. Dr
Watson completed his fellowship training in
Adult Reconstruction at Cornell University
Hospital for Special Surgery in New York
and his fellowship training for Orthopaedic
Trauma at Florida Orthopaedic Institute in
Tampa, Florida.
1. What was it about MiniHip™ that
appealed to you in the first place?
I have developed an arthroplasty practice
with a high percentage of younger
patients, many of whom bring a different
set of concerns and functional demands
when compared with our geriatric
patients. I was drawn to MiniHip™, as I
became concerned about the potential
issues with hip resurfacing. I still wanted
something designed to meet the demands
of fitter patients with good bone quality.
I feel MiniHip™ is an alternative bone
conserving / proximal bone loading
arthroplasty option for these
younger patients with high
functional demands and
good bone quality.
the MiniHip™ philosophy was an easy one
after a brief period of trialing this stem in
my practice. This was not the first ‘short
stem’ I’ve used and truly appreciating the
difference took a few cases. Once I got it –
that length and offset can be modulated to
the patients anatomy through the level the
neck cut it became my stem of choice for
patients with appropriate bone quality.
3. What were some of the initial hurdles
to overcome?
I was surprised at the intensity of the
learning curve I encountered, though in
retrospect with a better understanding of the
stem philosophy, I appreciate that it is unlike
switching between conventional stems. By
moving the neck cut to mid neck the bone
anatomy and quality changes compared to
that in a conventional neck cut. This takes
getting used to, to avoid intraoperative
angst and fracture complications I would
highly recommend cadaver training with an
experienced mentor. I’ve always templated
hip cases very methodically on the AP
pelvis but other than an assessment
of femoral anteversion spent little time
assessing the femoral neck on the lateral
projection. Stem fixation within the neck
requires rigorous templating on both AP
and lateral to truly anticipate and plan the
needed reconstruction.
4. What has your experience been like
using MiniHip™?
Positive. There was a learning curve and
patient selection is critical to success as this
is not a stem for every patient in my opinion. I
have been particularly pleased with the ability
2. How did you
make the decision
to adopt the
MiniHip™ stem
philosophy?
The decision
to adopt
MiniHip™
All opinions and advice expressed in this article are the surgeon’s and may not represent the opinions of Corin Group or its
affiliates. Use of any orthopaedic implant should be in line with the IFU guidelines and associated surgical technique.
6
Global surgeon feature
My experience with the Zenith™ Ankle
to reliably recreate a patient’s native length
and offset – even in those outliers with the
long valgus or high offset varus necks that
can be challenging with standard stems.
5. How is MiniHip™ different to other
short stems?
Simply put – it’s not just another short
stem. Length and offset are recreated
to match anatomy via the level of neck
resection. It’s bone conserving and most
importantly the preserved proximal bone
sees physiologic loading. This is not always
the case with other so-called ‘short stems’.
6. What are the three most important
things in your opinion with regard to
your outcomes with MiniHip™?
Maintenance / restoration of native
anatomy is a driver of patient satisfaction.
Hip arthroplasty reliably alleviates arthritis
pain regardless of stem design. MiniHip™
fine-tunes the reconstruction minimising
the early feelings of limb length inequality
and trochanteric bursitis that can detract
from accelerated rehab. With experience,
the stem design allows for implantation
with less soft tissue releasing (through a DA
approach). With this winning combination,
my MiniHip™ patients resume normal gait
earlier and with less pain.
7. How has MiniHip™ made a difference
in your practice?
There are two aspects to that question. The
first is clinical. Adoption of the MiniHip™ has
facilitated accelerated rehab protocols given
its natural fit with DA hip surgery, which in
turn helps with short stay and ambulatory
hip arthroplasty. With anatomic restoration
of length and offset in these patients the
shortened recovery has been impressive.
The second issue is marketing. Patients,
particularly the younger crowd tend to be
informed consumers with hours of internet
research under their belt. They are truly
engaged and appreciate the advantages
offered with MiniHip™ and I’ve witnessed
a growth in my practice with this segment
of patients.
Mr Shashi Garg,
MBBS, MS (orth),
FRCS, FRCS (orth)
Westmorland
General Hospital,
Kendal, UK
The number of total ankle replacement
(TAR) surgeries performed in the UK is
significantly lower than the number of
hip or knee replacements, with fusion
often seen as the preferred treatment
option for ankle arthritis. However,
TAR is considered to be a reasonable
alternative to ankle arthrodesis in
certain patient groups. Whereas ankle
arthrodesis eliminates movement of
the tibiotalar joint, TAR can maintain
dorsi/plantarflexion and allow patients
to recover a more normal walking gait
(especially helpful on inclines and stairs)
and to protect other joints of the foot,
in particular the Chopart joint, from
developing arthritis. Certain patients who
have bilateral ankle arthritis with arthritis
of hindfoot or midfoot will be more
suitable for TAR than arthrodesis.
I have been performing TAR surgery
since 2004, and started using the
Zenith™ implant in 2008 following
experience with the BP™ and Mobility™
systems. My decision to change to the
Zenith™ ankle replacement was due to
the design features of the implants and
the user-friendly instrumentation, and
I have performed 120 TARs using the
Zenith™ system. The talar component
has three flat cut surfaces with two pegs
providing good fixation and is suitable
for early weight bearing at two to three
weeks. The talar
jigs are well
designed and
The Zenith™ talar component incorporates
a patented ‘opening wedge’ design with
two anterior pegs providing initial implant
stability while the biomimetic cementless
coating on both tibial and talar components
allows good osseous integration for longterm stability.
The Zenith™ instrumentation includes cutting
guides that allow accurate, reproducible
parallel resection of the tibia and talus. I
strongly recommend that surgeons new to
TAR attend a Zenith™ ankle replacement
workshop including cadaveric surgery,
and visit experienced surgeons performing
surgery. All surgeons new to TAR should
start with simple cases with no deformity and
should invite experienced surgeons to assist
with initial cases.
Pre-op
Two years post-op
A recent review of 70 consecutive
patients1 who received a Zenith™ TAR
between April 2008 and March 2012
demonstrated 96% survivorship (a small
number of patients develop medial pain
in the first year following surgery but this
resolves spontaneously). Our patients
demonstrated very high patient satisfaction
at minimum three years follow-up.
Cysts remain a concern following TAR but
I now obtain preoperative CT scans of all
patients. It is interesting to see that 10%
of patients have cysts prior to surgery and
one patient underwent grafting of a cyst at
the same time as TAR surgery.
The Zenith™ TAR demonstrates good
medium-term survivorship. It produces
significant improvements in VAS and
AOFAS scores, with high patient
satisfaction and low risk of complications.
8. What do you feel is the key takeaway
from your clinical experience for
surgeons interested in MiniHip™?
It’s a great stem, probably best suited to
experienced hip surgeons. I would highly
recommend a training session with an
experienced user to discuss some of the
subtleties and shorten the learning curve.
Once adopted it’s hard not to love it.
To find out more about how the MiniHip™
bone conserving hip stem can meet
the needs of your younger, more active
patients please visit http://bit.ly/1zdnyGG
allow accurate cuts for talar component
implantation. I found this to be a great
improvement compared to earlier designs I
have used.
References
1.Presented at
BOFAS 2015
Zenith™
Total Ankle Replacement
All opinions and advice expressed in this article is the surgeon’s and may not represent the opinions of Corin group or its affiliates. Use of
any orthopaedic implant should be in line with the IFU guidelines and associated surgical technique.
Responsible Innovation
7
Clinical news
LARS™ – Managing lateral hip pain
In 1923 Stegemann et al.1 first described
‘juxta-trochanteric pain’ and attributed this
to the condition of trochanteric bursitis.
Bursitis implies that the condition must
involve an inflammatory component, but
more recently it has become apparent
that a number of different pathologies
could account for lateral sided hip pain.
Trochanteric bursitis is still used to describe
pain around the greater trochanteric region
of the hip despite the absence of key signs
of inflammation. Currently the most common
term used to describe this condition in
the literature is Greater Trochanteric Pain
Syndrome (GTPS).
LARS™
LARS™
tears seen in the shoulder3, are the most
common cause of GTPS4,5,6.
Patients usually present with chronic lateral
hip pain specifically located around the
greater trochanteric region and weakness of
the hip abductors, or tears can be identified
during, or subsequent to, hip replacement
surgery. X-ray can be used to exclude hip
joint involvement (OA) and MRI scans
have shown to be an accurate means of
diagnosing abductor tendon tears7.
Do current treatment modalities work?
Current conservative treatment options,
involving activity modifications, nonsteroidal anti-inflammatory medications,
physiotherapy and corticosteroid injections,
tend to show high symptom recurrence
rates at one year8. When conservative
treatment fails, the next logical step is
surgical investigation and repair of any
tendon tears. Whilst Walsh et al.9 reported
approximately 90% good results with suture
repair alone, patients were required to
remain non-weight bearing for six weeks.
Extended periods of non-weight bearing
can lead to additional postoperative
complications with 8.3% of patients
presenting with DVT in this study. Other
studies using suture and anchor based
surgical repairs have demonstrated good
initial pain relief but high re-rupture rates of
up to 31% at 12 months8 suggesting a more
robust repair is required.
LARS™ is a third generation synthetic,
incorporating a high strength, novel
design technology which minimises
postoperative strength loss and material
degradation11,12,13. As an augment, LARS™
provides immediate strength and stability
to the repair, with increased resistance
to elongation and low re-rupture rates,
thereby facilitating rapid return to function
and pain elimination post-surgery10,14,15.
LARS™
LARS™
How is LARS™ different in gluteal repairs?
Images from animation and live surgery video show
LARS™ sutured to the gluteal tendons and drawing the
tendons down to the footprint on the GT
What is GTPS attributable to?
GTPS is often misdiagnosed or neglected
due to a lack of clear understanding of
the pathology involved and uncertainty
surrounding how to treat patients. Patients
are commonly prescribed conservative
treatment options including antiinflammatory medication and physiotherapy.
Fearon et al.2 found that people with GTPS
had low levels of full time work participation
with pain and dysfunction levels
indistinguishable from patients with severe
osteoarthritis (OA) of the hip, awaiting total
hip arthroplasty. Recent improvements in
the understanding of the pathology of
GTPS have revealed that tears of the
gluteus medius or minimus muscles or their
tendinous insertions, similar to rotator cuff
Rotator cuff repairs are routinely protected
in an abduction sling, but this is impractical
in gluteal tendon repairs. Early mobilisation
may be a contributing factor to the high rerupture rates seen with traditional suture
based repairs. The use of LARS™ to
augment the repair aims to decrease
the stress of the repair in the ambulating
patient by spreading the load over a larger
surface area of the soft tissues, providing
an improved mechanical environment to
facilitate healing rates. The LARS™ ligament
is sutured to the deep surface of the gluteal
tendons, pulled through a bone tunnel in
the greater trochanter drawing the tendons
back on to the decorticated footprint. The
LARS™ is secured in the bone tunnel
using an interference screw and the repair
is completed using trans-osseous suturing
of the lateral portion of the tendons to the
trochanteric bone. Over 1200 gluteal tendon
repairs reinforced with LARS™ have been
performed in Australia with very high patient
satisfaction and low failure rates10, without
the need for patients to remain non-weight
bearing post-surgery. Reinforcing the gluteal
tendon repair with LARS™ allows patients
to be weight bearing as tolerated from 24
hours after surgery.
Images from animation and live surgery video show
LARS™ sutured to the gluteal tendons and drawing the
tendons down to the footprint on the GT
To view the LARS™ gluteal repair
surgical technique and learn more
about LARS™ indications please visit
www.bit.ly/1TX55on
References
1. Stegemann H. Arch Klin Chir. 1923.
2. Fearon A, et al. J Arthroplasty 2014.
3. Bunker TD et al. JBJS [Br]. 1997.
4. Williams BS et al. Anaesthesia and Analgesia. 2009.
5. Bird PA et al. Arthritis and Rheumatology. 2001.
6. Kingzett-Taylor A, et al. AJR. 1999.
7. Cvitanic O et al. AJR. 2004.
8. Davies H et al. Hip Int. 2009.
9. Walsh M et al. J Arthroplasty. 2011.
10.Bucher TA et al. Hip Int. 2014
11.LARS™ laboratory testing. Data held on file, Corin
Group PLC 2005.
12.Ardern CL et al. Arthroscopy. 2010.
13.Mascarenhas R et al. MJM. 2008
14.Bajwa AS et al. Hip Int. 2011
15.Holroyd B et al. European Musculoskeletal Review. 2009
All opinions and advice expressed in this article is the surgeon’s and may not represent the opinions of Corin group or its affiliates. Use of any orthopaedic implant should be in line with the IFU
guidelines and associated surgical technique.
8
Global surgeon feature
Use of Revival™ in treatment of CDH/DDH
to femoral anatomy and ease of surgical
restoration of the joint biomechanics.
Mr Duncan Whitwell
BMBS FRCS (Orth)
Nuffield Orthopaedic
Centre, Oxford, UK
The term ‘developmental dysplasia of
the hip’ (DDH) describes a spectrum of
disorders ranging from mild dysplasia of
the acetabulum or femur, to subluxation
and high dislocation of the hip joint. In
order to encourage normal development
of the hip joint, the femoral head must lie
congruently within the acetabulum. DDH
is the most common cause of secondary
osteoarthritis in young adults, a pathology
more frequently encountered in women
and in countries such as Japan.
As part of CDH/DDH the following are
often seen in the femur:
Excessive femoral neck anteversion, and
the variability in the degree of anteversion
has also been well documented.
Anteversion in DDH was 22.2° (SD 10.8)
compared with a mean of 14.3° (SD 6.8)
in normal hips, with a wide variation
from -3.2° to 58.2° in the DDH group1.
The medullary canal of the hypoplastic
femur narrows in both the mediolateral
and the anteroposterior planes, and the
shape of the often straight femoral canal
becomes more rotationally abnormal
with increasing subluxation2. The greater
trochanter is located more posteriorly. The
femoral neck is shorter and coronal plane
deformities have also been reported, with
increasing coxa vara noted with increasing
severity3. This unique set of symptoms in
the femur can make total hip arthroplasty
challenging. These requirements often
mean a conventional stem used for primary
THA is not appropriate. A modular stem
which allows for fixation of the stem
in the diaphysis of the femur is more
appropriate. This means offset and version
can be adjusted to recreate the required
biomechanics. Shorter stems are often
required for this type of patient due to
more distal deformity and to preserve as
much bone as possible at the time of
initial surgery. These patients are
often young, active patients
who may go on to require
future surgeries.
The Revival™ 100mm distal
stem is ideally suited for
these cases as stem size,
offset and neck length
are independent variables
which allow improved fitting
Distal stem length (mm)
Stem diameter (mm)
100 (straight)
14 16 18 20 22 24
■■
■■
■■
Conical stem with splines
Modular proximal body to set the
correct anteversion
Different stem diameters and proximal
body lengths
There have been some reported outcomes
on treatment of CHD/DDH with modular
stems. In this retrospective analysis of 61
modular neck prostheses implanted for DDH,
the cumulative survival was 97.5% at 11
years4. A study reporting 28 THRs in severely
subluxed or dislocated DDH using femoral
stems with a modular neck, showing no
femoral revisions or loosening at a mean of
ten years’ follow-up were reported.
In my opinion Revival™ is a good alternative
for treating this group of patients.
To find out how the Revival™ Revision
Hip Stem allows the surgeon to address
every patient effectively and efficiently
please visit www.bit.ly/1O4Ci1W
References
1. Liu RY et al. Acta Radiol. 2009
2. Noble PC et al. CORR . 2003
3. Robertson DD et al. CORR . 1996
4. Traina F et al. JBJS [Am]. 2009
COMPANY NEWS
South Africa
During the week of 11 - 15
April, Cape Town hosted the
13th Meeting of the Combined
Orthopaedic Associations
(COMOC). Corin South Africa were
proud to be part of this meeting, and
used it as a launch opportunity for
the Optomized Positioning System
(OPS™) in South Africa. OPS™ is a
unique technology offering significant
benefits for patients and surgeons
in optimising implant orientation in
total hip replacement. At the launch
event hosted on the Monday afternoon
Corin South Africa were privileged
to have a faculty of international
experts comprising of Dr Michael
Solomon (Sydney, Australia), Mr David
Woodnutt (Swansea, Wales) and Mr
Giles Stafford (London, UK). The
faculty presented their experience in
the use of the of the OPS™ technology
to the audience.
Following the launch event OPS™
generated significant interest on
the Corin booth for the entire week
as surgeons from all the attending
countries were keen to learn more
about this exciting technological
advancement. In addition to OPS™ we
showcased our comprehensive hip
portfolio with MiniHip™, TriFit TS™
and Trinity™ proving to be the most
popular products being discussed.
The focus on the knee side of the
booth was the Unity EquiBalance™
technology and the advantages this
instrument system offers patients
being treated with this implant. Corin
South Africa would like to thank all of
our customers for the valuable time
spent with us on the booth and for
the significant interest shown in our
exciting product portfolio.
Revival™
All opinions and advice expressed in this article is the surgeon’s and may not represent the opinions of Corin group or its affiliates.
Use of any orthopaedic implant should be in line with the IFU guidelines and associated surgical technique.
Responsible Innovation
9
Surgeon training
In the first six months of 2016 we have
been delighted to welcome Key Opinion
Leader surgeons from around the world
to our Global Headquarters and stateof-the-art manufacturing plant based in
Cirencester, England. During the course
of these visits surgeons meet with and
discuss their topics of interest with the
Executive Leadership Team as well as learn
about the progressive nature of Corin, why
we are at the cutting edge of arthroplasty
technology and how this enhances
individual patient care.
With the acquisition of the Optimized
Positioning System (OPS™) surgeons
are now even better placed to make
more accurate plans for surgery based
on the patient’s individual pelvic dynamic
movements whilst maintaining procedural
simplicity in the operating theatre, combined
these lead to more accurate personalised
cup positioning and precise restoration of
leg length, offset and combined anteversion.
We look forward to ever greater numbers
of surgeons visiting us, learning more about
the direction Corin is taking to enable better
end-to-end patient care and experiencing
the results of significant investment in our
state-of-the-art manufacturing facility.
In addition to visiting our facility we also
arrange personalised visits to meet Key
Opinion Leader surgeons in their theatres
and see how they are utilising Corin implants
and technologies to improve patient care.
If you would like the opportunity to visit
Corin’s Global Headquarters please
speak with your Corin representative or
distributor organisation. We very much
look forward to meeting you and helping
you experience Corin’s new facility and
our vision for the future.
Manufacturing facility at Corin’s Global Headquarters
PD Prof Dr Philip
Schöttle’s visit to
Corin Headquarters,
Cirencester, UK
Associate Professor
Schöttle visited us from
Munich where he runs the orthopaedic
department of the Isar Clinic. He performs
150 TKA procedures per annum and has
a special interest in ligament balancing
surgical techniques, this particular
attentiveness to soft tissue balancing of
10
the knee allowed us to share our thoughts
on the Unity Knee™ and more specifically
the soft tissue balancing instrumentation
options for our market leading device.
From right to left: PD Prof Dr Schöttle, Mr Klaus Clemens
(Corin GSA Managing Director), Mr Andrew Edwards
(Corin Group Manufacturing Director)
Associate Professor Schöttle is a dedicated
educator and surgical proctor who firmly
believes in a strong programme of surgeonto-surgeon training and thus is very well
aligned with the Corin Academy ‘Centres
of Excellence’ programme. Associate
Professor Schöttle commented:
“I was honoured to have been able to visit
Corin’s facilities in Cirencester. The way Corin
designs and manufactures is unique and
the feeling I get is that of a big family. The
concept and thinking behind OPS™ for the
hip and hopefully for the knee in the future
is astonishing. I very much enjoyed the open
discussion with the Product Management and
R&D teams about the Unity Knee™, the unique
thought process behind implanting a knee
replacement based on the specific needs of
each patient using a simple and reproducible
technique leads to many possibilities. I hope
to return soon, exchange more ideas and be
an active part of the Corin family, helping our
patients to reach their goals more effectively
than ever before.”
Dr Charles DeCook on
his visit to the Princess
Elizabeth Orthopaedic
Centre, Exeter, UK
“What an incredible trip!
I had the opportunity to
observe Mr Andy Toms in surgery putting in
anatomically aligned Unity knees, a great
opportunity to see such an accomplished
surgeon at work. I gained a better
appreciation for anatomic alignment as well
as the tremendous value of the EquiBalancer.
It was also very valuable to tour Corin’s
Global Headquarters in Cirencester. I think
you really have to visit to appreciate the
passion the entire group has around quality.
They clearly want to be the very best when it
comes to manufacturing joint implants and
it shows in everything they do. Their passion
permeated through each person I met. I
would highly recommend it to any surgeon
considering the trip.” – Charles DeCook, MD
Dr Paolo Camos visit
to University Hospital
of Coventry and
Warwickshire, UK
Visiting us from the
Saronno Hospital in
the Lombardia region of Italy, Dr Camos
has a keen interest in both hip and
knee arthroplasty. Following on from
his visit to our Global Headquarters
where he met with members of the
Executive Leadership Team and Product
Management, he was taken to the
University Hospital of Coventry and
Warwickshire to meet with Professor
King for the second day of his visit.
Professor King performed three Optimized
Positioning System (OPS™) cases with
Dr Camos, demonstrating the efficacy
of this technology to deliver accurate
placement of both acetabular cup and
hip stem based on the patient functional
requirements. Dr Camos observed:
“It was with great pleasure that I accepted
the invitation to visit both Corin in
Cirencester and Professor Richard King at
Rugby Hospital. I had the opportunity to
meet Executive Management, R&D and take
a tour around their new state of-the-art
manufacturing facility.
Manufacturing facility at Corin’s Global Headquarters
Surgeon support
I met a dynamic company focused on
innovation, specifically the personalisation
of patient care and procedural efficiency.
The focus is not on implant customisation
per-se but a functional, patient specific
plan and procedural simplicity in theatre.
This philosophy embraces my personal
approach to hip and knee arthroplasty.
I had the pleasure to assist Professor
Richard King during three total hip
procedures utilising Corin’s OPS™ system.
This peer-to-peer opportunity confirmed
to me the ability of Corin’s OPS™ platform
to precisely reproduce the preoperative
functional surgical plan. The OPS™
system represents a true innovation. I
am convinced that no two hips or knees
are the same and thus each patient
requires a specific plan. Professor King
was very kind, generous with his time,
and above all very professional. I had the
opportunity to exchange thoughts in a
comprehensive way, since sharing opinions
with him was extremely useful, I look
forward to continuing the relationship
with Professor King moving forward. I
would like to thank Corin and all their
staff who facilitated such an interesting
and enjoyable visit. A special thank you
to Professor Richard King for his time and
expertise, I look forward to reciprocating
his kindness and meeting with him in my
department in Italy.”
The start to 2016 has been a busy one
delivering on the product and sales training
needs of the sales forces around the world.
So far we have delivered Unity Knee™
training in both its basic and more advanced
forms to the UK sales force based on their
identified knowledge and experience level.
The second advanced Unity Knee™ sales
training course focused on key messages,
soft tissue balancing and selling against the
competition. We look forward to helping
to develop sales opportunities with the UK
team throughout 2016.
“I recently attended both the basic and
advanced Unity Knee™ product / sales
training courses and found them stimulating,
engaging and beneficial. The concept of MCL
isometry to eliminate paradoxical anterior
glide whilst allowing rotational freedom
and soft tissue-guided kinematics I can see
appealing to many surgeons, when you
partner this with the ligament balancing
device and soft tissue-guided motion I
anticipate winning key competitor business
utilising these powerful messages.” – Rob
Linsell – Sales Agent
Australia.
Product training,
4-25 February 2016
Australia continues to be a strategically
important market and the team here are
always excited to both deliver and take
part in training and development activities.
As well as running ‘train the trainer
sessions’ enhancing the ability of our local
team to run courses themselves, on this
occasion we also undertook assessment
and validation of previous trainings. In
addition we also worked closely with new
team members both in Perth and Brisbane
whose excitement, knowledge and active
engagement in the programme made
training a pleasure. Jordana Cashman,
National Sales and Marketing Manager for
Australia commented:
“The impact of Brian’s visit was to give
a strong focus on an area fundamental
to our success. Our structured learning
and development program empowers our
team with best-in-field knowledge and this
visit also accelerated our local capability
to independently deliver the program.
Ultimately, quality training elevates the
standard of Corin representation in the
market. We thank Brian for
his contribution, he is an
asset to our business.”
South Africa.
Product training, 18-24 March 2016
Corin SA continues to grow rapidly as
surgeons come to better understand
Corin’s core product portfolio and
services through the knowledge
and understanding of well-informed
representation. In addition to Cape Town
and Johannesburg we were delighted to
also welcome new team members from
Durban, Pretoria and KwaZulu-Natal.
Nico Wiese, General Manager
SA commented:
“As we continue to grow and expand into
new geographical regions within South
Africa, it is imperative that we engage
with our highly skilled team in order to
deliver best-in-market support to our
customers and their patients. Reliability of
service, in-depth product knowledge and
being at the cutting edge of personalised
treatment pathways are all important to
our surgeons.”
USA.
Medical compliance and credentialing
As the medical device industry continues
to expand globally, Corin USA is growing
at an exceptional rate. As part of this
growth it is important that not only do
we educate our sales talent in relation
to products and services but also better
prepare our team in the field to handle
the ever more complex regulatory
relationships with the surgeons and the
hospitals. Michel Rhee, Vice President –
General Manager Corin USA said:
“Corin takes great pride in providing highperforming sales agents with the skills to
deliver unmatched customer focused sales
and service. It is imperative that Corin
also provide compliance training to ensure
everyone is committed to abiding by the
laws and regulations while interacting
with health care professionals.”
Responsible Innovation
11
Charity news
Orthopaedic trauma relief in Africa
About ten years ago (October 2006) a
team of six British volunteers belonging to
the UK-based registered medical charity,
Motec Life UK supported by Corin Group
made a maiden working visit to Ghana full
of enthusiasm, ambition and hope. The
group planned to take personnel from the
UK to Ghana to provide orthopaedic-trauma
training, education and relief. A series of
working visits to Ghana including exchange
programmes between the sub-region and
British health workers from various health
institutions continue to this day, supported by
the British public and UK companies.
hip and knee replacements using Corin
products in Ghana each year with the active
participation of local staff, some of whom
have progressed to become independent
hip and knee surgeons. Motec is a non-profit
organisation, any funds generated by the
services in the hospitals are ploughed back
into on-going improvements in healthcare
delivery improving patient experiences.
The sad common story of the routinely
prescribed Girdlestone hip arthroplasty as
the primary surgical care for arthritic hips
is now consigned to history in Ghana. The
benefits of arthroplasty have transformed
the thinking of surgeons, patients and carers
in the West African sub-region. Arthroplasty
for disabling joint diseases has proven to be
an acceptable practice especially in younger
patients who are often in their ‘bread winning’
years. Arthroplasty plays a significant role in
returning patients to a socio-economically
productive group and contributing to the
wealth of their families and the nation.
Surgery preparation in Ghana
Motivated by the success of our surgeries
and perhaps the economic benefits of joint
arthroplasty, the number of orthopaedic
surgeons in Ghana has now increased
from about 15 to 50 over the last decade.
Patients waiting weeks for their trauma
and orthopaedic surgical care in targeted
orthopaedic hospitals has been eradicated,
through education and training on the impact
of early effective treatment and rehabilitation
of surgical and non-surgical patients.
For Motec’s strategy to deliver better and
safer orthopaedic trauma services in Ghana
the charity embarked on a programme of
training and education for orthopaedic trauma.
Surgeons, nursing staff, physiotherapists,
laboratory and plaster technicians, theatre
support workers, hospital administrators,
ward and outpatient staff and health policy
makers of the Ghana Health Service have
been the targeted group at the forefront of our
collaborative work in Ghana. Motec’s work
in training and education has extended to
member states of the West African College
of Surgeons (WACS, 16 member countries)
with support for improvements in the standard
of examinations in the exit Fellowship
examinations of WACS.
Motec makes three working visits to Ghana,
organises two national orthopaedic trauma
workshops and one Masterclass meeting
each year. This is mainly orthopaedic trauma,
hip and knee arthroplasty, arthroscopy,
and cruciate ligament reconstruction using
materials, implants and equipment from
Corin Group. This is always accompanied
by live surgeries. The teaching programme
involves the teaching hospitals, regional
orthopaedic health institutions in Ghana
and the West African College of Surgeons
collaborating with the London Post Graduate
School of Surgery. Some surgeons from
Ghana have had training post-appointment
in St Mary’s and St George’s Hospitals in
London and some observational attachments
in teaching hospitals throughout the UK.
Through this approach, from a modest
three major operations on the maiden visit
and a handful of orthopaedic surgeons
in Ghana, Motec now performs about 65
COMPANY NEWS
MetaFix™ collared
evaluation
Corin continues to develop its hip
portfolio with the introduction of the
MetaFix™ collared stem. This will be
available in a 125° and a 135° variant.
Additionally MetaFix™ collared will
have short necks in the smaller sizes to
accommodate better recreation of the
anatomy. Evaluations have begun in
the USA and UK. Around 75 MetaFix™
collared stems have been implanted
to date with promising results and
positive feedback from the evaluator
surgeons. We will
continue to
monitor the
evaluation
cases and we
anticipate
the UK
and USA
evaluation to
be completed
by the end of June
with commercial launch
expected in Q3 2016.
LARS™ PCL
From left to right: Mr Paul Ofori-Atta, HE President John
Atta Mills (late)
On the public front, attracted by the news
of Motec’s campaign, The President of
Ghana His Excellency President John Atta
Mills (late) held meetings with Motec at his
office during which discussions were held
on ways and means to help Ghana benefit
from the training and provision of specialist
orthopaedic services. Motec has also had the
honour of an audience with HM The Queen
and HRH Princess Anne in London.
www.bit.ly/1TX55on
The organisation is guided by a consortium
of patrons led by Lord David Alton. Motec
wishes to express its profound gratitude
to Corin Group, the British public and the
Ghanaian authorities for their support of our
humanitarian work.
Courtesy of Mr David Houlihan-Burne,
Consultant Knee Surgeon, BSc MB BS
MRCS FRCS (Tr & Orth), The Fortius
Clinic, London, UK
Important: Not all products are available or cleared for distribution in all international markets. For more details, please
contact your local subsidiary or distributor by visiting the Corin worldwide section.
www.coringroup.com
www.linkedin.com/company/corin-uk-ltd
info@coringroup.com
www.youtube.com/user/coringroup/
+44 (0) 1285 659 866 www.coringroup.com/surgeonresourcehub
Get in touch
If you are interested in hearing more
about our company or want more
information about our products please
complete the form on www.coringroup.com/articulate